Sovaldi (sofosbuvir)/Olysio (simeprevir)

♤ Sofosbuvir (brand name Sovaldi) is a drug to treat hepatitis C infection.

♤ The U.S. FDA has approved a breakthrough therapy for treatment of chronic hepatitis C that is expected to offer a more palatable cure to millions of people infected with the liver-destroying viral disease.

♤ Sovaldi (sofosbuvir) is the first drug that has demonstrated safety and efficacy to treat certain types of HCV infection without the need for co-administration of interferon.

♤ Olysio (simeprevir) a similar purpose drug was also approved recently.